患者特征无法预测降压药物个体化反应:一项交叉试验
该前瞻性、开放标签、盲法终点交叉试验纳入10家家庭诊所新诊断高血压患者120例,比较氢氯噻嗪与缬沙坦各4周(洗脱期4周)的降压反应。
要点
- 在新诊断高血压初级保健患者中,年龄、性别、肾素、NT-proBNP等均不能预测两药降压反应差异。
- 个体收缩压反应差异较大,从升高18 mmHg至降低39 mmHg。
- 结果支持美欧指南而非英荷指南关于一线降压药选择的立场。
核心结论
- 在新诊断高血压的初级保健患者中,未检测到可预测降压治疗反应的预测因素。
主要发现
- 所研究的变量均不能预测两种药物间收缩压反应差异。
- 个体收缩压反应范围从升高18 mmHg至降低39 mmHg。
关键数值与推荐
- 患者接受12.5 mg氢氯噻嗪每日一次4周和80 mg缬沙坦每日一次4周,每种药物后洗脱4周,用药顺序随机。
- 主要结局为两种研究药物间收缩压反应差异,基于日间动态血压均值计算。
临床怎么用
- 初级保健中不应依据患者特征常规选择一线降压药物类别,治疗选择需结合其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: International guidelines on hypertension management do not agree on whether patient characteristics can be used for the first choice of treatment of uncomplicated essential hypertension. OBJECTIVE: We wanted to identify predictive patient characteristics to the response of two different classes of antihypertensive drugs in patients with newly diagnosed hypertension in primary care. METHODS: We conducted a prospective, open label, blinded endpoint cross-over trial in 120 patients with a new diagnosis of hypertension from 10 family practices. Patients received 4 weeks of 12.5 mgr hydrochlorothiazide once daily and 4 weeks of 80 mgr valsartan once daily, each followed by a 4-week washout. The sequence of drugs was randomized. Age, sex and menopausal state were recorded at run in and 24 h ambulatory blood pressure, office blood pressure, plasma renin concentration, NT-proBNP, potassium, estimated glomerular filtration rate, urinary albumin, body mass index and waist circumference at each regimen change. The difference in systolic blood pressure response between both study drugs, calculated from mean daytime ambulatory blood pressures, was the main outcome measure. RESULTS: Ninety-eight patients (52% female; median age 53 years) were eligible for per-protocol-analysis. None of the studied variables were predictive for the difference in systolic blood pressure response. Individual systolic blood pressure responses ranged from an increase by 18 mmHg to a decrease of 39 mmHg. CONCLUSION: In a relevant group of primary care patients with newly diagnosed hypertension, we were unable to detect predictors of treatment response. This study rather supports the United States and European guidelines than the United Kingdom and Dutch guidelines on hypertension.
引用
- van der Wel MC, Biermans M, Akkermans R, et al. Patient characteristics do not predict the individual response to antihypertensive medication: a cross-over trial. Fam Pract. 2018. PMID: 28968870. doi:10.1093/fampra/cmx075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。